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Heightened distractibility is a core symptom of Attention Deficit Hyperactivity Disorder 
(ADHD). Effective treatment is normally with chronic orally administered psychostimulants 
including amphetamine. Treatment prevents worsening of symptoms but the site of 
therapeutic processes, and their nature, is unknown. Mounting evidence suggests that the 
superior colliculus (SC) is a key substrate in distractibility and a therapeutic target, so we 
assessed whether therapeutically-relevant changes are induced in this structure by chronic 
oral amphetamine. We hypothesized that amphetamine would alter visual responses and 
morphological measures. Six-week old healthy male rats were treated with oral amphetamine 
(2, 5 or 10 mg/kg) or a vehicle for one month after which local field potential and multiunit 
recordings were made from the superficial layers of the SC in response to whole-field light 
flashes in withdrawal. Rapid Golgi staining was also used to assess dendritic spines, and 
synaptophysin staining was used to assess synaptic integrity. Chronic amphetamine increased 
local field potential responses at higher doses, and increased synaptophysin expression, 
suggesting enhanced visual input involving presynaptic remodelling. No comparable increases 
in multiunit activity were found suggesting amphetamine suppresses collicular output 
activity, counterbalancing the increased input. We also report, for the first time, five different 
dendritic spine types in the superficial layers and show these to be unaffected by 
amphetamine, indicating that suppression does not involve gross postsynaptic structural 
alterations. In conclusion, we suggest that amphetamine produces changes at the collicular 
level that potentially stabilise the structure and may prevent the worsening of symptoms in 
disorders like ADHD. 
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1. Introduction 
Distractibility is defined as an attentional deficit where orientation toward irrelevant targets 
cannot be inhibited (Gaymard et al., 2003). Heightened levels of distractibility are found 
within a variety of psychiatric conditions, including Attention Deficit Hyperactivity Disorder 
(ADHD) (Douglas, 1983; Thorley, 1984) and schizophrenia (Grillon et al., 1990). It is also found 
within healthy ageing (Gaymard et al., 2003; Mishra et al., 2014) where it is believed to 
underpin a decline in various cognitive functions, therefore impacting negatively on quality 
of life in otherwise healthy people (Kim et al., 2007). Despite the high prevalence of 
heightened distractibility, limited attempts have been made to understand its basis within the 
brain, with focus almost exclusively on the prefrontal cortex and associated cortical networks 
(Campbell et al., 2012; Chadick et al., 2014). However, converging evidence implicates the 
superior colliculus (SC) as a key neural substrate for distractibility. The colliculus is responsible 
for orienting head and eye movements (Grantyn et al., 2004) and covert attention toward 
sensory stimuli (Rizzolatti et al., 1987). It is highly conserved across species and work in a 
range of species shows that collicular lesions cause decreased distractibility (Goodale et al., 
1978; Milner et al., 1978; Sprague and Meikle, 1965), while removal of prefrontal cortex 
inhibitory control of the colliculus, leading to heightened activity in the structure, results in 
increased distractibility in humans (Gaymard et al., 2003). Additionally, there is evidence that 
the colliculus may play a role in ADHD, a core symptom of which is heightened distractibility 
(Brace et al., 2015a, b; Dommett et al., 2009; Dommett and Rostron, 2011; Klein et al., 2003; 
Milner et al., 1978; O'Driscoll et al., 2005; Swanson et al., 1991).  
A key role for the colliculus in distractibility is possible because of intricate connections to the 
basal ganglia, a series of nuclei believed to act as the central device for action selection 
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(Gurney et al., 2001; Redgrave et al., 1999). The colliculus makes direct connections to 
dopaminergic neurons in substantia nigra pars compacta and the ventral tegmental area 
(Comoli et al., 2003; Dommett et al., 2005; Takakuwa et al., 2017). In turn the structure also 
receives dopaminergic input (Bolton et al., 2015; Perez-Fernandez et al., 2017; Rolland et al., 
2013). As well as this dopaminergic input, the colliculus receives extensive GABAergic input 
from the substantia nigra pars reticulata (Hikosaka, 2007; Kaneda et al., 2008). Recent 
research suggests that when this GABAergic input is reduced, the effects of dopamine on the 
colliculus are revealed such that reduced dopamine activity is associated with enhanced visual 
responses (Rolland et al., 2013). As well as these connections with the basal ganglia both the 
superficial and deep layers of the SC have direct ascending connections to the thalamus. In 
the case of the superficial layers of the SC, which process visual information, this  is to the 
lateral posterior  nucleus and the pulvinar and then forward to the neostriatum (McHaffie et 
al., 2005), or via a link in the deep layers of the SC (Lee et al., 1997), which project to the 
rostral intralaminar regions of the thalamus on route to the neostriatum (McHaffie et al., 
2005). Where collicular activity is enhanced, via these connections the structure can make a 
stronger bid for behavioural expression and is therefore more likely to win against 
competitors resulting in an increased probability of orienting eye and head movements (and 
covert attentional shifts) which can ŵĂŶŝĨĞƐƚ ĂƐ  ?ĚŝƐƚƌĂĐƚŝŽŶ ? ? ŽŶǀĞƌƐĞůǇ ? ďǇ ĚĞƉƌĞƐƐŝŶŐ
responses in the SC, the probability of orienting movements and attentional shifts would be 
reduced (Dommett et al., 2009).  
Increased distractibility is not always treated, but amphetamine has been found to be 
effective in reducing distractibility in ADHD (Brown and Cooke, 1994; Spencer et al., 2001) 
and in healthy subjects (Agmo et al., 1997; Halliday et al., 1990). Although the 
psychostimulant is efficacious, it ?Ɛ therapeutic mechanism of action is still unknown. 
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However, there is now mounting evidence that the colliculus could be a key site of action. For 
example, acute amphetamine has been shown to suppress activity in the visually responsive 
superficial layers of the SC in healthy animals (Dommett et al., 2009; Gowan et al., 2008) and 
in rodent models of ADHD (Clements et al., 2014). In addition, we have recently demonstrated 
that chronic treatment with orally-administered amphetamine selectively alters collicular-
dependent behaviour in a manner consistent with suppression of activity in the area (Turner 
et al., 2018a). Furthermore, amphetamine is known to act on dopaminergic neurons to 
increase synaptic dopamine levels, and based on previous research (Rolland et al., 2013) we 
can infer that this should suppress visual responses in the colliculus. Evidence suggests that 
chronic treatment with amphetamine (or methylphenidate) in patients prevents the 
worsening of ADHD symptoms that occurs on a short time scale in a proportion of placebo-
administered controls (Faraone et al., 2002), hence chronic drug treatment for ADHD clearly 
leads to changes that assist the therapeutic process. However, the nature of those changes 
and their location is currently unknown.    
To assess whether therapeutically-relevant changes occur at the level of the SC following 
chronic psychostimulant administration, we chronically administered amphetamine orally to 
rats at a range of doses and examined the impact of the drug on visual processing and 
structural characteristics in the two-week period immediately after drug treatment, which we 
considered to be when the animal is in withdrawal. Research has consistently shown that 
chronic amphetamine treatment impacts on spine density and dendritic remodelling 
elsewhere in the brain (Robinson and Kolb, 1997, 1999; Selemon et al., 2007) and that these 
changes can be detected within 2 weeks and persist for several months (Acerbo et al., 2005; 
Kolb et al., 2003; Li et al., 2003; Robinson and Kolb, 1997, 1999). In line with this, there is 
evidence of altered expression of synaptophysin, a synaptic protein involved in regulation of 
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vesicular exocytosis (Bergmann et al., 1993; Grabs et al., 1994), following amphetamine 
administration in several structures (Bisagno et al., 2004; Rademacher et al., 2006; 
Rademacher et al., 2007; Stroemer et al., 1998). Based on this previous research, we 
hypothesized that chronic treatment with amphetamine would alter visual responses in the 
colliculus and dendritic and synaptic measures within the structure.   
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2. Methods and Materials 
All experiments were approved by the Institutional Ethical Review Committee at the Open 
University, where work took place (The Animal Welfare and Ethics Board). Work was also 
conducted with the authority of the appropriate UK Home Office Licenses and adhered to 
guidelines set out in the Animals [Scientific Procedures] Act (1986), EU Directive 86/609/EEC, 
ĂŶĚƚŚĞ ?'ƵŝĚĞĨŽƌƚŚĞĐĂƌĞĂŶĚƵƐĞŽĨ>ĂďŽƌĂƚŽƌǇŶŝŵĂůƐ ?(Council, 2010).  
2.1 Subjects 
Male Hooded Lister rats, bred in-house and housed in standard conditions as previously 
described (see Supplementary Material 1 (Turner et al., 2018a, b) were used in all 
experiments. All procedures were carried out in the dark phase and, therefore, when rats are 
most active.  
2.2 Chronic drug treatment 
Oral administration of amphetamine (Sigma Aldrich, UK) or vehicle in apple juice was 
conducted as previously described (Turner et al., 2018a, b; Wheeler et al., 2007) and is 
therefore detailed in the Supplementary Material 1. Drugs were administered daily for 4 
weeks (excluding weekends) for a total of 20 days (Kuczenski and Segal, 2002). All treatment 
took place in the holding room, after daily weighing of the rats (to determine dose and 
monitor health status), at the start of the dark phase. Three doses of amphetamine were 
selected (10 mg/kg, 5 mg/kg, and 2 mg/Kg) to ensure some clinical relevance and included 
those that have previously been shown to impact on collicular-dependent behaviours (Turner 
et al., 2018a). The final day of treatment fell on a Friday and in all cases subsequent 
procedures were conducted between 3 and 14 days after treatment end are summarised in 
Figure 1. Previous work has demonstrated that some effects associated with amphetamine 
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withdrawal can be found as within 24 hours after treatment cessation (Barr et al., 2010; Barr 
et al., 2013) and can persist for over 14 days (Hitzemann et al., 1977; Onn and Grace, 2000; 
Renard et al., 2014; Robinson and Kolb, 1997). The exact duration of any effect is likely to 
depend on the exact treatment regime and effects on some measures may persist for longer 
than others. The 3-14 day period selected here was chosen because existing literature 
suggested effects of withdrawal would be present for this whole period and it allowed 
sufficiently-sized cohorts to be used, bearing in mind the time consuming nature of some of 
the techniques, especially the in vivo electrophysiology. 
 
Figure 1: An overview of the experimental paradigm with sample sizes for each technique 
and drug treatment. 
2.3 Acute Electrophysiology 
2.3.1 Surgical preparation 
Animals were initially anaesthetised with 4% isoflurane (Abbott Laboratories, Maidenhead, 
UK) followed by an intraperitoneal (i.p.) injection of 30% Urethane (5ml/kg, Sigma Aldrich, 
Gillingham, UK). Anaesthetic depth for surgery was assessed by loss of the pedal and eye blink 
reflexes. Both eyes were sutured open and liquid tear gel (Viscotears®, Novartis 
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Pharmaceuticals Ltd., Surry, UK) applied to prevent desiccation. The animal was then placed 
in a stereotaxic frame (Kopf Instruments, Tujunga, USA) in the skull flat position. Body 
temperature was measured throughout the experiment using a rectal thermometer 
connected to a thermostatically-controlled heating blanket (Harvard Apparatus Ltd, 
Edenbridge, UK) to maintain temperature at 36- ? ? ȗ ? &ŽůůŽǁŝŶŐ ĂƉƉůŝĐĂƚŝŽŶ ŽĨ ůŽĐĂů
anaesthetic (Ethyl Chloride BP, Cryogesic ®, Acorus Therapeutics Ltd., Chester, UK), scalp 
retraction, bilaterial craniotomy and durotomy were performed, creating two 3 mm Ø burr 
holes exposing the cortex above the SC (right:-6.3 mm AP to Bregma, and +2 mm ML to the 
midline; left: -6.3 mm AP to Bregma; and +3.5 mm ML to the midline) to allow for 
simultaneous recordings from both SCs. In addition, two trepanned holes (1 mm Ø) were 
created anterior to the SC burr holes at specific stereotaxic co-ordinates for 
electroencephalographic (EEG) recordings (+1 mm anterior, +2 mm lateral; and -4mm 
posterior, +3mm lateral, relative to Bregma, (Devonshire et al., 2009). Differential and active 
EEG electrodes (loop-tipped silver wire, 0.2 mm Ø; Intracel) were placed ~1 mm subcranially 
into the rostral and caudal trepanned holes, respectively, to obtain continuous EEG 
information. Finally, respiration rate was recorded using a three-axis accelerometer IC 
(ADXL330KCPZ, Analog Devices, Norwood, MA, USA) ĚĞǀŝĐĞĂƚƚĂĐŚĞĚƚŽƚŚĞĂŶŝŵĂů ?ƐůĂƚĞƌĂů
abdomen (Devonshire et al., 2009). Both EEG and respiration rate were used to monitor the 
animal during the recordings and used offline to confirm there were no differences in 
anaesthetic depth between the groups. 
2.3.2 Recording procedure 
Tungsten electrodes (Parylene-C-ŝŶƐƵůĂƚĞĚ ?  ? DA? ? -M Systems Inc., Carlsborg, WA, USA) 
were positioned directly above the superficial layers of the SC at the coordinates stated above 
at a depth of  ? 2.0 mm from the brain surface. The electrodes were then gradually lowered 
10 
 
during presentation of a light stimulus (green LED flashing at 0.5 Hz, 10 ms duration, 20 mcd 
positioned 5 mm anterior to the contralateral eye) until a strong light response was detected 
in both the audio feed from the recording (NL120, The Neurolog System, Digitimer, 
Hertfordshire, UK) and visual feed via Spike2 (CED, Cambridge, UK). Once the electrodes were 
positioned in the superficial layers, the animal remained in the dark for a further 25 min to 
adapt to the darkness before actual recordings began. Visual responses from 150 stimulations 
were then recorded at five different stimulus intensities (from minimum to maximum light: 
4, 8, 12, 16 and 20 mcd). For all recordings, extracellular low frequency (local field potential; 
LFP) and high-frequency (multiunit activity) signals were amplified (gain 10,000 and 1000, 
respectively), band-pass filtered (LFP: 0.1 ?500 Hz, multiunit activity: 500 ?10 kHz) (Logothetis, 
2008), digitized at 11 kHz and recorded to PC using a 1401+ data acquisition system 
(Cambridge Electronic Design Systems, Cambridge, UK), running Spike2 software (Cambridge 
Electronic Design, Cambridge, UK) and saved for offline analysis.  
2.3.3 Reconstruction Histology 
Following all recordings, a direct current of 10 µA was passed through the each of the 
electrodes for 5 s (Constant Voltage Isolated Stimulator DS2A MK2, Digitimer, Welwyn Garden 
City, UK) to mark the recording site. The animals were then transcardially perfused with 
physiological saline followed by 4% paraformaldehyde in phosphate buffered fixative. The 
brains were then placed in fixative for 24 h before being transferred to 20% sucrose for a 
further 36 h. They were then frozen to -18ȚC in isopentane (WWR International, Lutterworth, 
UK) and cut into 50 µm coronal sections using a cryostat (CM1900, Leica, Milton Keynes, UK) 
with the cutting chamber held at -20ȚC. The slices were dehydrated with alcohol and Nissl 
stained with cresyl violet (0.5%) (Sigma Aldrich, Gillingham, UK), before cover-slipping for  
ŚŝƐƚŽůŽŐŝĐĂů ǀĞƌŝĮĐĂƚŝŽŶ ŽĨ ƌĞĐŽƌĚŝŶŐ ƐŝƚĞƐ ? ǁŚŝĐŚ were subsequently plotted onto 
11 
 
reconstructed sections from Paxinos and Watson (Paxinos and Watson, 1998) to confirm 
location of recording in the superficial layers of the colliculus.  
2.3.4 Data Processing 
Waveforms were filtered using a low pass filter to give local field potential (LFP) data and high 
pass filter to give multiunit activity. The local field potential data was used to produce a 
waveform average in Spike2 (1 s duration, 0.1 s offset) for each stimulus intensity. This was 
exported into Matlab (Mathworks, Massachusetts, United States) to extract three response 
parameters: onset latency, peak latency and peak-to-peak amplitude. A response was 
deemed to have occurred if the voltage trace exceeded a pre-determined threshold after 
stimulus onset, but not before 20 ms post stimulus. The latter requirement was used to avoid 
any stimulus-related artifacts; collicular LFP responses to light flash stimuli in dark-adapted 
rats have been reported to have an average onset latency more than 27 ms (Dyer and Annau, 
1977; Gowan et al., 2008). The threshold for change was set at ±1.96 standard deviations (i.e. 
within 95% confidence levels) from the mean activity during the pre-stimulus baseline, that is 
the 100 ms prior to the light flash. For the multiunit responses, PSTHs were produced in Spike2 
(1-ms bins, 1 s duration, 0.1 s offset) and the data was exported into Matlab for extraction of 
response parameters: onset latency, peak latency and amplitude. As with the LFP data, a 
response was deemed to have occurred if the trace exceeded a threshold of ±1.96 standard 
deviations from the mean activity in the 100 ms pre-stimulus baseline period.  
2.3.5 Statistical analysis 
All statistical analysis was completed in SPSS. Chi-square tests of independence were used to 
assess whether treatment with amphetamine affected the likelihood of an LFP or multiunit 
response at each stimulus intensity. Where responses were found, parameter measures (i.e. 
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latencies and amplitude) were confirmed as suitable for use in parametric tests using the 
Kolmogorov-Smirnov test and measures of kurtosis and skewness. Repeated measures 
ANOVAs were then used with CHRONIC DOSE as the between-measures factor and STIMULUS 
INTENSITY as the within-measures factor. Significant main effects were further analysed with 
within-subject contrasts (simple and difference) and post-hoc Tukey tests for the within-
measures and between-measures factors respectively. Where there was a significant 
interaction effect, tests of simple effects were run. These tests allow examination of the 
effects of one variable at the individual levels of the other variable and are an accepted 
method to investigate significant interactions (Field, 2009). If the assumption of sphericity 
was violated, the Greenhouse-Geisser results were reported (Greenhouse and Geisser, 1959). 
In all cases effect sizes are reported for statistical tests, with partial eta-squared (ɻp2) reported 
ĨŽƌEKsƐĂŶĚƌĂŵĞƌ ?ƐsƌĞƉŽƌƚĞĚĨŽƌchi-square analyses (Kim, 2017; Richardson, 2011).  
To check that the depth of anaesthesia was comparable in the different chronic treatment 
groups during testing, the dominant EEG frequency was obtained using a power spectrum 
analysis (Spike2) for the full 300 s of each recording (i.e. 150 stimulations).  The respiration 
rate per min was calculated during the first and last 30 s of this period and then used to 
calculate an average rate per min over the whole recording period. Based on the EEG 
frequency bands, all animals were found to be in stage III-3 or III-4 (Guedel, 1920). There were 
no significant differences in the dominant EEG frequency between the chronic treatment 
groups (F (3, 60) = 0.22, p = 0.881, ɻp2 = 0.01).  They were also found to have comparable 
respiration rates (F (3, 44) = 2.34, p = 0.087, ɻp2 = 0.15). 
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2.4 Anatomical measures - Golgi Staining  
2.4.1 Histological methods 
Animals were sacrificed by i.p. injection of pentobarbatone (Animalcare, York, UK), perfused 
with 0.9 % saline and fixed with 1 % glutaraldehyde and 2 % paraformaldehyde in 0.1 M PB. 
The brain was removed and stored in 2.5 % glutaraldehyde in 0.1 M PB for at least 24 h before 
being switched to 4 % paraformaldehyde until staining begun. Brains were placed in slicing 
moulds and sections approximately 3 mm thick were collected through the SC. These sections 
were then rinsed briefly in 0.1 M PB and treated in 1 % osmium tetroxide for at least 7 h or 
overnight, then transferred to 3.5 % potassium dichromate and left at 4 °C for 4 days, with 
agitation of the sample on day two. Sections were then immersed in 1.5 % silver nitrate and 
the precipitate was gently cleared with a paint brush. The sections were kept in silver nitrate 
for 4 days at 4 °C. Following staining the sections were rinsed in 70 % ethanol, the precipitate 
was cleared and the section was mounted in agar to prevent cracking. Sections were sliced 
using a vibrating microtome (VT1000, Leica, Milton Keynes, UK) using a high frequency and 
low speed. The sections were preserved by dehydration in ethanol, and cover slipping using 
DPX (VWR International, Lutterworth, UK).  
Within the SC, we randomly sampled neurons and dendrites for analysis. This random 
sampling method was applied across all superficial layers ensuring suitable coverage of the 
structure. In total 227 dendrites were analysed (mean ± SEM 11.95 ± 1.23 dendrites per 
animal), with no significant differences in the number sampled per animal across treatment 
groups (F(3, 15) = 0.294, p = 0.0829). Data were collected from different order dendrites, with 
the majority (43.6%) being first order, followed by second order (37%) with the remain sample 
consisting of third (15%), fourth (3.5%) and fifth (0.9%) order, with the order of dendrites 
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sampled comparable across groups (F(3, 23) = 1.85, p = 0.140). The minimum dendritic length 
analysed was 30.10 µm with an average length of 95.13 ± 5.0 µm (SEM). The length of the 
dendrites sampled was also comparable across groups (F(3, 223) = 1.23, p = 0.398). The 
average thickness of traced dendrites was 1.11 ± 0.17 µm, also not significant differing 
between groups (F(3, 223) = 0.936, 0.424) Spine type was recorded, using morphological 
criteria previously defined (Risher et al., 2014). Briefly, a spine was defined as: thin if its length 
exceeded its width; stubby if the length is equal to or less than its width; mushroom if it has  
a long or short spine neck with large head (diameter >  0.6  µm); filopodia if its length is at 
least twice the width and there are no bulbous head regions and finally; branched if there is 
more than one head region on one spine neck. Spine density was measured using Neurolucida 
neuron tracing software (MBF Bioscience, Williston, VT, USA) by creating an image stack 
through the z-axis, tracing the length of the dendrites and marking each spine occurrence. 
Density was calculated by dividing the number of spines through by the length of the dendrite 
(Risher et al., 2014). 
2.4.2 Statistical analysis of dendritic measures 
All analyses were completed within SPSS where data was first confirmed as suitable for use 
in parametric tests using the Kolmogorov-Smirnov test and measures of kurtosis and 
skewness. A repeated measures ANOVA, using CHRONIC DOSE as a between-measures factor 
and SPINE TYPE as a within measures factor was used to analyse the percentage of each spine 
type. Spine density data was analysed using a One-Way ANOVA to identify any significant 
differences between dose groups. As with the electrophysiology data, partial eta-squared is 
reported as an effect size, along with the p-value. 
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2.5 Synaptic integrity - synaptophysin 
2.5.1 Immunohistochemical methods 
Animals were sacrificed by i.p. injection of pentobarbatone (Animalcare, York, UK), perfused 
with 0.9 % saline and fixed with 4 % paraformaldehyde in 0.1 M PB. The brain was then 
removed and stored in fixative for at least 24 h, then transferred to 20 % sucrose for at least 
36 h. Brains were frozen to -20 °C in isopentane (VWR International, Lutterworth, UK) and 
coronal sections were sliced using a cryostat (CM1900, Leica, Milton Keynes, UK) at a 
thickness of 50 µm. Sections were collected through SC and stored free floating in 
cryoprotectant storage solution until staining. Sections were warmed to room temperature 
and 4 sections per animal were chosen, each approximately 6.3 mm posterior to bregma. 
Sections were rinsed in 0.1 M phosphate buffer, then placed in 1% sodium borohydrate for 
30 min. Sections were subsequently rinsed in phosphate buffer until the cessation of 
effervescence. Sections were then placed in 3% hydrogen peroxide for 15 min before being 
rinsed again in phosphate buffer. Sections were then left in incubation buffer for 1 h, then 
incubated in 1:1000 dilution of mouse anti-synaptophysin (Sigma-Aldrich, Gillingham, UK) 
antibody overnight. The sections were then rinsed in phosphate buffer and incubated in a 
1:200 dilution of biotinylated donkey anti-mouse IgG antibody (Jackson, Pennsylvania, USA) 
for 1 h, then rinsed in phosphate and Tris buffers. A peroxidase ABC kit was used to stain the 
tissue and DAB was then used to develop the stain. After rinsing in Tris buffer, sections were 
mounted on glass slides and air dried for two days before being dehydrated in ethanol, 
cleared in xylene and cover slipped with DPX. Each slide was then photographed using a 
Microfibre digital camera attached to a Nikon Eclipse 80i microscope (Nikon UK LTD, Kingston-
upon-Thames, UK). Image stacks through the z axis were obtained in 10 random locations 
across the SC for each section. Images were then analysed using ImageJ. First, stacks were 
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merged through the z axis, then the background was subtracted, and the image converted to 
16-bit before thresholding and water-shedding images to display just the synaptophysin 
puncta. Imaging and thresholding parameters were kept uniform for each image.  
2.5.2 Analysis of synaptophysin  
Analysis was performed using the ImageJ analyse particles function to determine the total 
number of puncta, and the percentage area covered by puncta staining. These figures, along 
with the total area (µm2) of the image, were then used to calculate the size and density of the 
puncta. Statistical analysis of the data was conducted in SPSS where it was first confirmed as 
suitable for use in parametric tests using the Kolmogorov-Smirnov test and measures of 
kurtosis and skewness. A One-Way ANOVA was then conducted for each of the four 
parameters (number, area, size, and density) and reported with both p-values and effect size. 
3. Results 
3.1 Chronic amphetamine affects local field potentials more than multiunit activity 
Complex local field potential visual responses were found to at least one stimulus intensity in 
98% of recordings (N=127) (Figure 2A). The responses in the vehicle-treated control group 
across all intensities showed an average onset latency of 29.0 ± 4.0 ms (mean ± SEM) and a 
peak latency of 95 ± 6.0 ms. The average peak-to-peak amplitude in this group was 127.00 ± 
18.4 µV.  Analysis of the responses found of all animals indicated that for local field potential 
responses, there was no significant association between chronic dose and whether a visual 
response was found at any stimulus intensity (4 mcd: ʖ2 (3) = 0.91, p = 0.882, V = 0.084; 8 mcd 
ʖ2 (3) = 1.01, p = 0.798, V = 0.089, 12 mcd ʖ2 (3) = 0.99, p = 0.804, V = 0.088, 16 mcd ʖ2 (3) = 
4.81, p = 0.187, V = 0.193 and 20 mcd ʖ2 (3) = 2.51, p = 0.474, V = 0.139), indicating that chronic 
treatment with amphetamine did not impact on the likelihood of a local field potential visual 
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response. Repeated measures ANOVA revealed a main effect of STIMULUS INTENSITY on 
onset latency (Figure 2B, F (4.61, 271.17) = 13.76, p < 0.001, ɻp2 = 0.12). Within-subject 
contrasts revealed a significant decrease in onset latency, i.e. responses were faster at the 
highest two stimulation intensities relative to the first (i.e. 4 mcd < 16 mcd, 4mcd < 20 mcd) 
and to the one immediately prior (i.e. 12 mcd < 16 mcd, 16 mcd < 20 mcd). There was also a 
significant main effect of CHRONIC DOSE (F (3, 104) = 6.00, p = 0.001, ɻp2 = 0.15), with post-
hoc Tukey tests showing the onset latency to be significantly increased in all dose groups 
relative to the vehicle group (2 mg/kg p = 0.022, 5 mg/kg p = 0.018, 10 mg/kg p = 0.001), 
although the drug groups did not differ from each other. There was no significant interaction 
(F (7.82, 271.17) = 0.82, p = 0.587, ɻp2 = 0.02). Unlike onset latency, there was no significant 
main effect of STIMULUS INTENSITY on peak latency (Figure 2C, F (2.50, 259.95) = 0.56, p = 
0.695, ɻp2 = 0.01), although there was still a main effect of CHRONIC DOSE (F (3, 104) = 3.98, 
p = 0.010, ɻp2 = 0.10).  However, on this occasion this main effect was related to latencies in 
the 2 mg/kg group being significantly shorter than the 5 mg/kg (p = 0.01) and the 10 mg/kg 
(p = 0.049) groups, with no difference relative to the control group. There was however, also 
a significant interaction between CHRONIC DOSE and STIMULUS INTENSITY (F (7.50, 259.95) 
= 2.47, p = 0.016, ɻp2 = 0.07). Tests of simple effects of STIMULUS INTENSITY within each 
CHRONIC DOSE level showed that peak latency changed significantly with stimulus intensity 
for only the 5 mg/kg dose only (F (4) = 5.02; p = 0.001); it remained unaffected by stimulus 
intensity for all other dose groups. The simple effects test of CHRONIC DOSE within each level 
of STIMULUS INTENSITY revealed there were significant differences between the different 
drug groups for the first (4 mcd) stimulus intensity (F (3) 4.28, p=0.007) and the final (20 mcd) 
stimulus intensity (F (3) = 5.78, p = 0.001). At the first stimulus intensity, the 2 mg/kg group 
had significant longer latency than the vehicle-treated (p=0.011) and 10 mg/kg group 
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(p=0.019), whilst at the final stimulus intensity, the 5 mg/kg group had a longer latency than 
the vehicle-treated group (p=0.005) and the 2 mg/kg group (p=0.001). 
As may be expected there was a significant main effect of STIMULUS INTENSITY on response 
amplitude (Figure 2D, F (1.67, 173.48) = 11.00, p < 0.001, ɻp2 = 0.10), with significant increases 
in amplitude with each increase in stimulus intensity from 8 mcd to 20 mcd (p < 0.01). There 
was no significant main effect of CHRONIC DOSE (F (3, 104) = 2.06, p = 0.110, ɻp2 = 0.06). 
However, there was a significant interaction between STIMULUS INTENSITY and CHRONIC 
DOSE (F (5.00, 173.48) = 2.37, p = 0.042, ɻp2 = 0.06). Tests of simple effects of STIMULUS 
INTENSITY within each CHRONIC DOSE level showed that amplitude changed significantly with 
stimulus intensity for the 5 mg/kg (F (4) = 6.41; p < 0.001) and 10 mg/kg (F (4) = 9.60, p < 
0.001), but remained unaffected by stimulus intensity for the other dose groups. The simple 
effects test of CHRONIC DOSE within each level of STIMULUS INTENSITY revealed there were 
no significant differences between the different drug groups for all but the final (20 mcd) 
stimulus intensity (F (3) = 2.73, p = 0.048), where the 10 mg/kg group had a significantly larger 
response than the 2 mg/kg group (p=0.049). 
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Figure 2: A typical local field potential response to a visual stimulus in the superficial 
layers of the colliculus in a vehicle-treated animal. Example at mid intensity (12 mcd) 
delivered at time shown by dashed line. Vertical scale bar = 400 µV; horizontal scale bar = 
50 ms (A). Line graphs to show the relationship between stimulus intensity and onset 
latency (B), peak latency (C) and peak-to-peak amplitude (D) for the different chronic 
treatment groups. Analysis and data is shown for recordings only where r esponses were 
found at all intensities (Total sample N=108: Vehicle N=29, 2 mg/kg N=28, 5 mg/kg N=29 
and 10 mg/Kg N=22). A representative key is shown in (B). In all cases numerical data 
presented is as the mean ± SEM. 
 
Overall, visual responses were found to at least one stimulus intensity in 94% of the multiunit 
recordings made (N=121). A typical response is shown in Figure 3A. Responses in our vehicle-
treated control group averaged across all stimulus intensities had an onset latency of 66.0 ± 
2.0 ms and a peak latency of 114.0 ± 4.0ms, with an amplitude of 879 ± 89 spikes/sec. There 
was no significant association between chronic dose and whether a visual response was found 
at any intensity for all animals (4 mcd: ʖ2 (3) = 2.46, p = 0.483, V = 0.138; 8 mcd ʖ2 (3) = 1.50, 
p = 0.682, V = 0.108, 12 mcd ʖ2 (3) = 7.76, p = 0.051, V = 0.245, 16 mcd ʖ2 (3) = 2.81, p = 0.421, 
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V = 0.148 and 20 mcd ʖ2 (3) = 3.94, p = 0.268, V = 0.175), indicating that chronic treatment 
with amphetamine did not impact on the likelihood of a visual response. A repeated measures 
ANOVA showed a significant main effect of STIMULUS INTENSITY on onset latency (Figure 3B, 
F (2.82, 214.40) = 445.33, p < 0.001, ɻp2 = 0.85). Within-subject contrasts showed a significant 
reduction in onset latency between each consecutive stimulus intensity (p<0.001). There was 
also a significant main effect of CHRONIC DOSE (F (3, 76) = 2.97, p = 0.037, ɻp2 = 0.11), although 
post hoc Tukey tests revealed only trend level differences between the 5 mg/Kg group and 
both the control group (p = 0.061), and 2 mg/Kg dose group (p = 0.081), with the onset latency 
being consistently faster in the control and low dose groups. There was no significant 
interaction effect between the STIMULUS INTENSITY and CHRONIC DOSE (F (8.46, 214.40) = 
1.78, p = 0.079, ɻp2 = 0.07).  There was however a significant main effect of STIMULUS 
INTENSITY on peak latency (Figure 3C, F (2.98, 226.72) = 3.87, p = 0.01, ɻp2 = 0.05). Within-
subject contrasts revealed that only at the penultimate stimulus intensity was the peak 
latency significantly less than the first (p < 0.001). There was no significant main effect of 
CHRONIC DOSE (F (3, 76) = 0.626, p = 0.601, ɻp2 = 0.02), however there was a significant 
interaction effect between STIMULUS INTENSITY and CHRONIC DOSE (F (8.95, 226.72) = 2.35, 
p = 0.015, ɻp2 = 0.07). Tests of simple effects of STIMULUS INTENSITY within each CHRONIC 
DOSE level showed that peak latency changed significantly with stimulus intensity for the 5 
mg/kg (F (4) = 2.71; p=0.006) and 10 mg/kg (F (4)= 3.37, p = 0.010) doses, but remained 
unaffected by stimulus intensity for the other dose groups. The simple effects test of CHRONIC 
DOSE within each level of STIMULUS INTENSITY revealed there were no significant differences 
between the different drug groups for all but the final (20 mcd) stimulus intensity (F (3) =3.77, 
p=0.014), where the 5 mg/kg dose had a significantly longer latency than the vehicle-treated 
group (p=0.045) and the 2 mg/kg group (p=0.038). 
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Finally, there was a significant main effect of STIMULUS INTENSITY on response amplitude 
(Figure 3D, F (1.89, 143.57) = 218.88, p < 0.001, ɻp2 = 0.74) with within-subject contrasts 
showing a significant increase in response amplitude with each consecutive rise in stimulus 
intensity (p < 0.001). There was no significant effect of CHRONIC DOSE (F (3, 76) = 0.69, 
p=0.563, ɻp2 = 0.03), and here was also no significant interaction effect (F (0.82, 143.57) = 
0.79, p=0.576, ɻp2 = 0.03). 
 
Figure 3: A typical multiunit response to a visual stimulus in the superficial layers of the 
colliculus in a vehicle-treated animal. Example at mid intensity (12 mcd) delivered at time 
shown by dashed line. Vertical scale bar = 100 spikes/sec; horizontal scale bar = 50 ms (A). 
Line graphs to show the relationship between stimulus intensity and onset latency (B), 
peak latency (C) and peak-to-peak amplitude (D) for the different chronic treatment 
groups. Analysis and data is shown for recordings only where responses were found at all 
intensities (Total sample N=80: Vehicle N=23, 2 mg/kg N=19, 5 mg/kg N=21 and 10 mg/Kg 
N=17). A representative key is shown in (B). In all cases numerical data presented is as the 
mean ± SEM. 
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3.2 Chronic amphetamine does not affect spine types or densities 
Five different spine types were identified within the colliculus: thin, stubby, mushroom, 
filopodia and branched (Figure 4A). A repeated measures ANOVA was used to analyse the 
proportion of these different spine types. This revealed no significant main effect of CHRONIC 
DOSE (F (3, 15) = 0.63, p = 0.610, ɻp2 = 0.11), and no interaction effect (F (5.87, 29.35) = 0.90, 
p = 0.506, ɻp2 = 0.153). However, there was a significant main effect of SPINE TYPE (Figure 4B, 
F (1.96, 29.35) = 73.24, p < 0.001, ɻp2 = 0.83). Contrasts revealed that there were no significant 
differences between the percentage of thin and stubby spines overall (p=0.995). However, 
there were significantly more thin and stubby spines than any other type (p A? 0.001) of spine. 
Additionally, there were more mushroom spines than both filopodia and branched (p < 0.001) 
and more filopodia than branched (p < 0.001). As well as there being no differences between 
groups in terms of the types of spines present, a One-Way ANOVA found no significant 
differences in spine density between different chronic treatment groups (Figure 4C, F (3, 15) 
= 1.05, p = 0.401, ɻp2 = 0.17).  
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Figure 4: Examples of different dendritic spines in the superior colliculus (Scale bar = 5 µm) 
T=thin, S=stubby, M=mushroom, F=filopodia and B=branched (A). The proportion of 
different spine types in the colliculus showed a predominance of thin and stub by spines 
but no differences between chronic drug groups (B). There were also no significant 
differences in spine density (C). In all cases numerical data presented is as the mean ± 
SEM. ** p<0.001. 
3.3 Chronic amphetamine increases the size of synaptophysin-positive puncta 
Analyses of synaptophysin measures (Figure 5A and B) using One-Way ANOVA showed no 
significant differences in the number of synaptic puncta (F (3, 17) = 0.75, p = 0.536, ɻp2 = 0.12), 
the percentage area covered by puncta (F (3, 17) = 1.07, p = 0.389, ɻp2 = 0.16) or the density 
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of the puncta (F (3, 17) = 0.86, p = 0.482, ɻp2 = 0.13) between the chronic treatment groups. 
However, there was a significant difference in the average size of the puncta (Figure 5C, F (3, 
17) = 10.45, p < 0.001, ɻp2 = 0.65). Post hoc Tukey tests revealed that the vehicle-treated 
control group had significantly smaller puncta in comparison to the 10 mg/Kg group (p = 
0.024), and the puncta of the 2 mg/Kg group were significantly smaller than both the 10 
mg/Kg (p < 0.001) and the 5 mg/Kg groups (p = 0.009). 
 
Figure 5: An example of synaptophysin stained tissue, merged through the z -axis (A). An 
image following thresholding to display just the stained synaptophysin puncta (B).  Scale 
bar = 10 µm. Variation in puncta size between the different drug groups (C). In all cases 
numerical data presented is as the mean ± SEM. * p<0.05, ** p<0.001. 
4. Discussion 
In line with previous studies, we recorded complex LFP responses in the superficial layers of 
the SC in response to whole-field light flashes (Clements et al., 2014; Dyer and Annau, 1977; 
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Gowan et al., 2008). The response parameters in the vehicle-treated control group were 
consistent with previous work in drug-naïve dark-adapted rats for both latencies (Dyer and 
Annau, 1977; Hetherington et al., 2017) and peak-to-peak amplitude (Clements et al., 2014). 
We found a relationship between stimulus intensity and onset latency, whereby the response 
was faster at higher stimulus intensities, which has been previously demonstrated in the 
absence of chronic amphetamine treatment (Clements et al., 2014; Dyer and Annau, 1977). 
This relationship was found for all drug groups, and therefore appears unaffected by dose, 
even though all doses of amphetamine significantly increased onset latency. The finding that 
chronic amphetamine treatment significantly increased onset latency during withdrawal has 
parallels with acute administration work where it has been found to increase the latencies of 
LFPs at higher doses (Gowan et al., 2008).  By contrast, although peak latency was affected by 
chronic dose, amphetamine did not produce any systematic variation from the vehicle-
treated control group for this parameter, in line with acute amphetamine effects (Clements 
et al., 2014). 
As would be expected from the literature (Gowan et al., 2008) we reported that peak-to-peak 
amplitude of the LFP response was increased with increasing stimulus intensity. However, we 
found a significant interaction between drug dose and stimulus intensity, which suggested 
that the increase in peak-to-peak amplitude of the LFP response with increasing stimulus 
intensity was driven largely by increases in the 5 mg/kg and 10 mg/kg groups at the higher 
stimulus intensities. GŝǀĞŶ ƚŚĂƚ ƚŚĞ >&W ƌĞƐƉŽŶƐĞ ŝƐ ďĞƐƚ ĚĞƐĐƌŝďĞĚ ĂƐ ƌĞƉƌĞƐĞŶƚŝŶŐ  ?ƉĞƌŝ-
ƐǇŶĂƉƚŝĐĂĐƚŝǀŝƚǇ ? ?ǁŚŝĐŚŝŶĐůƵĚĞƐƉŽƐƚ-synaptic potentials (Ekstrom, 2010; Logothetis, 2008), 
these data suggest that chronic amphetamine treatment with a high dose of amphetamine 
enhances incoming signals to the colliculus, albeit only for those high intensity signals.  
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Multiunit responses were similar in onset and peak latency as well as peak amplitude in our 
control group to those found in previous studies (Clements et al., 2014; Gowan et al., 2008). 
A similar relationship to that found for LFP responses was demonstrated for stimulus intensity 
and onset latency, with the latency decreasing as intensity increased. Also similar to the LFP 
data we found an increase in response amplitude with increasing stimulus intensity. However, 
unlike the LFP data this was found for all groups and not a result of preferential increases in 
the groups treated with the higher amphetamine doses. Also, unlike LFP responses, we found 
that peak latency decreased, albeit only at the highest stimulus intensity and largely due to a 
decrease in the animals treated with the higher doses of amphetamine. It is possible to 
speculate that chronic treatment with higher doses of amphetamine, whilst increasing the 
strength of incoming excitatory signals, suppresses the impact of those signals on collicular 
activity via some form of neuroadaptation, resulting in a mismatch of effect on LFP and 
multiunit activity. One possible mechanism for this is that amphetamine decreases the 
number of transient voltage-gated sodium channels, increasing the threshold for action 
potential generation in the colliculus. This has been found previously for other brain regions 
following chronic treatment with amphetamine, albeit given intraperitoneally (Peterson et 
al., 2006). This suppression would be consistent with our behavioural effects previously 
reported which suggest that chronic amphetamine treatment reduces activity in the colliculus 
and suppresses collicular dependent behaviour (Turner et al., 2018a).  
There were no significant differences between groups in terms of dendritic spine density or 
expression of different spine types. This is perhaps surprising given previous research 
revealing significant increases in spine density in rodents following chronic amphetamine 
treatment (Robinson and Kolb, 1997, 1999). However, in this previous work, data indicated 
that the increase in density may have come from an increase in branched spines which were 
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not prevalent in the colliculus. Additionally, the increases seen previously in the prefrontal 
cortex and nucleus accumbens have not been replicated in all other areas (Selemon et al., 
2007) indicating this may not be a common action of amphetamine but specific to these limbic 
and cortical structures. In the present context, the lack of impact of chronic amphetamine on 
spine parameters suggests ƚŚĂƚǁŚĂƚĞǀĞƌŶĞƵƌŽĂĚĂƉƚĂƚŝŽŶƐƵŶĚĞƌůŝĞĐŚƌŽŶŝĐĂŵƉŚĞƚĂŵŝŶĞ ?Ɛ
suppressive effect on collicular activity in response to excitatory inputs, this is not mediated 
by post-synaptic structural changes.  
Despite not revealing any effects of chronic drug administration on dendritic spines in the SC, 
our study is, as far as we are aware, the first investigation of the SC using the adapted rapid 
Golgi method and therefore, the general pattern of spine types is of interest. The most 
prevalent spine types within the SC were stubby and thin spines, often suggested to be the 
earliest in development from filopodia (Harris, 1999). This could indicate that much of this 
region may be in the early stages of synaptogenesis (Yuste and Bonhoeffer, 2004). Further 
evidence of this is seen by the presence of a significant number of dendritic filopodia, which 
are often believed to be precursors of dendritic spines (Morest, 1969; Ziv and Smith, 1996), 
and previous studies have found that filopodia can be found abundantly during periods of 
rapid synaptogenesis, but as the dendrite matures the populations of filopodia are replaced 
by more spine like structures (Dailey and Smith, 1996; Ziv and Smith, 1996). However, there 
is also evidence to suggest that spines do not develop along a single directional pathway with 
the exact role of filopodia unclear and therefore this interpretation should be considered with 
caution (Hering and Sheng, 2001). Future studies may consider further analysis of spine types 
at multiple time points to better understand these characteristics of collicular morphology. 
Additionally, such studies should differentiate between different neuron types within the 
colliculus to best understand any impact of changes on the function of local circuitry. 
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The present study did reveal changes in synaptophysin staining indicating some alterations to 
synaptic functioning. Whilst there were no significant differences in the number of synaptic 
puncta, area they covered or density, there was a significant difference in the size of the 
puncta between groups, with the control group having significantly smaller puncta than the 
highest (10 mg/Kg) dose group, and the lowest (2 mg/Kg) dose group having significantly 
smaller puncta that both the 5 and 10 mg/Kg groups. The impact of amphetamine on 
synaptophysin could indicate that the colliculus is sensitive to amphetamine-induced 
remodelling (Bisagno et al., 2004). Previous work reporting an increase in puncta size in 
another brain region associated it with synaptic enhancement, suggesting that neurons 
contacted by presynaptic terminals with a larger synaptophysin content are likely to show 
increased mEPSC frequency (Misra et al., 2010). This is consistent with our electrophysiology 
results which indicated that at the higher doses there was a greater amplitude of LFP response 
to high stimulus intensities. However, as suggested above, this increased incoming signal may 
be compensated for by a decreased response within the colliculus, removing any 
corresponding increase in multiunit activity. It is not possible from the current data to 
establish which, if either, of these changes occurred first i.e. whether amphetamine increased 
the synaptophysin content which was then compensated for by a reduction in the number of 
transient voltage-gated sodium channels or vice versa. However, given that acute 
administration of amphetamine has been previously found to reduce multiunit responses 
(Gowan et al., 2008), it is possible to speculate that this was the initial effect of amphetamine. 
This is also in line with previous work showing that a reduction in dopamine causes an 
increase in visual responses (Rolland et al., 2013), such that amphetamine, by increasing 
dopamine levels would suppress activity. Indeed, we have previously hypothesized that one 
mechanism of action of amphetamine in conditions such as ADHD, where it reduces 
29 
 
distractibility, may be to suppress collicular activity (Brace et al., 2015a; Clements et al., 2014; 
Hetherington et al., 2017; Overton, 2008). If this were to be the case, the upregulation of 
synaptophysin could be a neuroadaptation to moderate the impact of amphetamine on 
collicular output. The existence of this compensatory balance may explain the evidence in the 
literature that amphetamine has sustained efficacy as a treatment for ADHD without evidence 
of improved efficacy over time (Fredriksen et al., 2014). However, since synaptophysin 
changes have been demonstrated in response to withdrawal from amphetamine treatment 
(admittedly from a shorter period of i.p. administration)  (Subramaniam et al., 2001), we have 
to acknowledge that  the changes in synaptophysin in our study may have been an acute 
response to withdrawal. That aside, the preservation of collicular visual output in the face of 
enhanced collicular input suggests that some of the changes that attend chronic 
amphetamine administration that prevent a worsening of symptoms may take place in the 
SC. 
There are several limitations to the current study must be acknowledged. Firstly, whilst every 
effort has been made to ensure doses are therapeutically relevant and administered using an 
appropriate method to best mirror human use, we did not measure blood plasma levels, 
something that should be considered in future research. Secondly, the age of the animals in 
the present study (adult) would limit the applicability of the results to children with ADHD. 
However, given that the condition is now accepted to be present in adults as well children 
and the two cohorts are deemed distinct (Moffitt et al., 2015) these results do still have 
relevance to the clinical population. Thirdly, we did not examine the effects on the colliculus 
during chronic treatment and only in withdrawal and therefore to further dissect the effects 
of chronic treatment from the effects of withdrawal, future studies should consider collecting 
measurements during both phases. Finally, whilst research in animals has contributed much 
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to our understanding of the superior colliculus and the structure is highly conserved across 
mammalian species, there are variations in sensory processing between rodents, as used 
here, and humans, and the impact of such processing on attentional processes including 
distractibility. For example, rodents do not rely on vision as a primary sense and instead use 
their whiskers to explore the environment (Castro-Alamancos and Favero, 2016; Lee et al., 
2016), although with training they can use their visual system as effectively on attentional 
tasks (Lee et al., 2016). Although the intermediate layers of the colliculus contribute to 
whisker input processing, it cannot be assumed that effects of amphetamine equivalent to 
that found here ŝŶƚŚĞǀŝƐƵĂůůĂǇĞƌƐǁŽƵůĚďĞĨŽƵŶĚŝŶƚŚĞƌŽĚĞŶƚ ?ƐĚŽŵŝŶĂŶƚƐĞŶƐŽƌǇƐǇƐƚĞŵ ?
To date, this has not been investigated, although other psychostimulant treatment has been 
found to alter barrel cortex responses to whisker stimulation (Bekavac and Waterhouse, 
1995), indicating this could be worth investigating. 
Based on the current findings and the limitations described there are several future directions 
that could be considered. Prior to any further work investigating potential mechanisms of 
action of orally administered amphetamine, studies should be undertaken to directly 
compare the pharmacological effects and pharmacokinetics of the drug in humans and rats 
to ensure comparability. Additionally, to unpack the cellular mechanisms of action it would 
be helpful to consider conducting in vitro studies to investigate the effects of chronic 
amphetamine on the transient voltage-gated sodium channel currents, as has been 
completed for acute treatment in the prefrontal cortex (Peterson et al., 2006). Similarly, 
whilst we opted to randomly sample neurites for Golgi staining within the superficial layers 
for this study, the first of its kind; further work should consider systematic analysis of neurites 
from specific types of neurons within the colliculus in response to both vehicle treatment and 
amphetamine treatment of different durations. Finally, the work conducted here was 
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completed during a discrete withdrawal period and, therefore, it is not possible to definitively 
distinguish between the effects of different phases of withdrawal. As such future work should 
considered staggered experimentation with animals experiencing different durations of 
treatment and withdrawal. 
5. Conclusion 
In conclusion, we have shown, for the first time, the effects of chronic amphetamine 
treatment on visual responses in the colliculus in withdrawal. Results indicate that chronic 
amphetamine enhances the visual input to the SC, but that this does not translate into an 
enhanced visual output from the SC. Additionally, we have described the five different types 
of dendritic spine present in the superficial layers of the colliculus and shown these to be 
unaffected by amphetamine treatment, indicating the previous effects of amphetamine on 
dendritic measures may be region specific. Finally, we have found changes in synaptic 
integrity, as measured by synaptophysin puncta size. Collectively these results suggest that 
chronic amphetamine ?Ɛ ĞŶŚĂŶĐĞŵĞŶƚ ŽĨ ǀŝƐƵĂů ŝŶƉƵƚ ƚŽ ƚŚĞ ^ ŝƐ ŝŶ ƉĂƌƚ ŵĞĚŝĂƚĞĚ ďǇ
presynaptic remodelling involving synaptophysin. Furthermore, drug-induced suppression of 
collicular output activity (needed to balance out the effect of the enhanced input) does not 
involve gross postsynaptic structural alterations. We suggest that because chronic 
amphetamine produces changes at the collicular level that seem to balance out, this 
potentially stabilises the structure and may prevent the worsening of symptoms in disorders 
like ADHD. 
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